These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32034440)

  • 1. Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes.
    Gibb FW; McKnight JA; Clarke C; Strachan MWJ
    Diabetologia; 2020 May; 63(5):906-914. PubMed ID: 32034440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
    Hope SV; Knight BA; Shields BM; Hill AV; Choudhary P; Strain WD; McDonald TJ; Jones AG
    Diabetologia; 2018 Jan; 61(1):66-74. PubMed ID: 28983693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
    Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
    Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
    Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
    Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.
    Buckingham B; Cheng P; Beck RW; Kollman C; Ruedy KJ; Weinzimer SA; Slover R; Bremer AA; Fuqua J; Tamborlane W;
    Diabetologia; 2015 Jun; 58(6):1167-74. PubMed ID: 25773405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric estimated average glucose in children with Type 1 diabetes.
    O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
    Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes.
    Dover AR; Strachan MWJ; McKnight JA; Stimson RH; Mackenzie SD; Lyall MJ; Wright RJ; Forbes S; Gibb FW
    Diabet Med; 2021 Mar; 38(3):e14445. PubMed ID: 33128811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.
    Murphy HR; Elleri D; Allen JM; Simmons D; Nodale M; Hovorka R
    Diabet Med; 2012 Oct; 29(10):e361-4. PubMed ID: 22804483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world outcomes with different technology modalities in type 1 diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked improvement in HbA
    Tyndall V; Stimson RH; Zammitt NN; Ritchie SA; McKnight JA; Dover AR; Gibb FW
    Diabetologia; 2019 Aug; 62(8):1349-1356. PubMed ID: 31177314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
    Christensen MB; Gæde P; Hommel E; Gotfredsen A; Nørgaard K
    Diabetes Metab; 2020 Feb; 46(1):61-65. PubMed ID: 30796973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of flash glucose monitoring on glycemic control varies with the age and residual β-cell function of patients with type 1 diabetes mellitus.
    Zhang L; Xu Y; Jiang X; Wu J; Liu F; Fan L; Li X; Yin G; Yang L
    J Diabetes Investig; 2022 Mar; 13(3):552-559. PubMed ID: 34637185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
    Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
    Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
    Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
    Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes.
    Brandt R; Park M; Wroblewski K; Quinn L; Tasali E; Cinar A
    Diabetologia; 2021 Oct; 64(10):2159-2169. PubMed ID: 34136937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved C-peptide secretion is associated with higher time in range (TIR) on intermittently scanned continuous glucose monitoring in Chinese adults with type 1 diabetes.
    Liu W; Ma Y; Cai X; Zhu Y; Zhang M; Li J; Chen J; Shi D; Ji L
    Endocr Connect; 2022 Nov; 11(11):. PubMed ID: 36136936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.